Departments & Organizations
Dr. Justin Belsky completed his Emergency Medicine Residency at Henry Ford Hospital followed by a Research Fellowship studying sepsis at Massachusetts General Hospital. His research focus is on the early identification of sepsis through biomarkers as well as the role of Thymosin Beta 4 and Actin proteins in the pathogenesis of sepsis.
Dr. Belsky is the Yale site principal investigator for the clinical trial VICTAS which is a multicentered study comparing the efficacy of Vitamin C, Thiamine, and Hydrocortisone in patients with septic shock.
Education & Training
|MPH||Harvard School of Public Health (2016)|
|MD||Wayne State University School of Medicine (2011)|
|Research Fellowship||Massachusetts General Hospital|
|Resident||Henry Ford Hospital|
|Board Certification||AB of Emergency Medicine, Emergency Medicine (2015)|
Honors & Recognition
Sepsis Care Redesign, Partners in Excellence Team AwardPartners Health (2016)
Outstanding PosterShock Symposium (2015)
American College of Emergency Physicians (2015 - Present) Research Committee